TransCode Therapeutics, Inc.
(NASDAQ: RNAZ)
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
8.636
+0.226
(+2.69%)
Range
8.480 - 8.780
(3.54%)
Open
8.480
Previous Close
8.410
Bid Price
5.860
Bid Volume
10
Ask Price
6.410
Ask Volume
10
Volume
3,263
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
